Laser capture microdissection: Beyond functional genomics to proteomics

Molecular Diagnosis

Volumn 5, Issue 4, 2000, Pages 301-307

  Simone, N L ^a   Paweletz, C P ^a   Charboneau, L ^a   Petricoin III, E F ^a   Liotta, L A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Immunoassays; Matrix assisted laser desorption ionization time of flight spectrometry; Microdissection; Proteomics; Surface enhanced laser desorption spectrometry

Indexed keywords

CANCER DIAGNOSIS; CELL POPULATION; DISEASE COURSE; GENE EXPRESSION; HUMAN; LASER; MOLECULAR BIOLOGY; PROTEIN ANALYSIS; REVIEW; TUMOR CELL LINE;

EID: 0034436318     PISSN: 10848592     EISSN: None     Source Type: Journal    
DOI: 10.1054/modi.2000.19808a     Document Type: Article

References (30)

1. Laser capture microdissection
2. Laser capture microdissection: Opening the microscopic frontier to molecular analysis
3. Effects of fixation on RNA extraction and amplification from laser capture microdissected tissue
4. Analysis of PRL, PRL-R, TGFb1, and TGFb-RII gene expression in normal and neoplastic breast tissues after laser capture microdissection
5. In vivo gene expression profile analysis
6. Laser capture microdissection provides key to gene behavior
7. Gene expression profiles of laser-captured adjacent neuronal subtypes
8. Molecular profiling of clinical tissue specimens, feasibility and applications
9. Immunoblot analysis of CD34 expression in histologically diverse neoplasms
10. Positional cloning of the gene for multiple endocrine neoplasia type 1
11. PTEN, a putative protein tyrosine kinase phosphatase gene mutated in human brain, breast, and prostate cancer
12. The genetics of cancer - A 3D model
13. Proteome research: Complementarity and limitations with respect to the RNA and DNA worlds
14. The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis
15. An approach to the proteomic analysis of human tumors
16. (SELDI) Biomarker profiling of stages of cancer progression directly from human tissue using a protein biochip
17. Protein chip surface enhanced laser desorption/ionization (SELDI) mass spectrometry: A novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures
18. The role of immunohistochemistry and fluorescence in situ hybridization for Her-2/neu in assessing the prognosis of breast cancer
19. Role of HER2 gene overexpression in breast carcinoma
20. Detection and quantitation of the human Neu oncoprotein
21. Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system
22. The clinical pattern of HER-2/neu oncogene overexpressing breast cancer in Pakistani patients at initial presentation: An analysis of HER-2/neu positive versus negative disease - A preliminary report
23. Immunohistochemical determination of HER-2/neu expression in invasive breast carcinoma
24. Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection
25. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, β-chorionic gonadotrophin, and prostate-specific antigen
26. Ultrasensitive detection of prostate specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemilumenescent third generation assay
27. Immuno-LCM: Laser capture microdissection of immunostained frozen sections for mRNA analysis
28. New goals for the human genome project
29. The Cancer Genome Anatomy Project: Building an annotated gene index